A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. Study of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) Academic Article 2005 uri icon

authors

  • Maurel J
  • Dorta FJ
  • Casinello J
  • Llanos M
  • Aranda E
  • Sastre J
  • García-Ribas I
  • CARRATO MENA, ALFREDO
  • García-López JL
  • Bretón JJ
  • León A
  • Gallego J
  • Sánchez-Rovira P
  • Fernández-Martos C
  • Galán MC
  • Florián J

publication date

  • 2005